1,238 results on '"Celli, Bartolome R."'
Search Results
2. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
3. Identifying chronic obstructive pulmonary disease from integrative omics and clustering in lung tissue
4. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience
5. Optimal NIV Medicare Access Promotion: Patients With Hypoventilation Syndromes A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society
6. Optimal NIV Medicare Access Promotion: Patients With Central Sleep Apnea A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society
7. Executive Summary Optimal NIV Medicare Access Promotion: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society
8. Optimal NIV Medicare Access Promotion: Patients With OSA A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society
9. Optimal NIV Medicare Access Promotion: Patients With COPD A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society
10. Optimal NIV Medicare Access Promotion: Patients With Thoracic Restrictive Disorders A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society
11. COPD and multimorbidity: recognising and addressing a syndemic occurrence
12. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
13. Prevalence and prognostic importance of exercise limitation and physical inactivity in COPD
14. Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease
15. Genetically Predicted Body Mass Index and Mortality in COPD
16. Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
17. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients
18. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort
19. Sex differences between women and men with COPD: A new analysis of the 3CIA study
20. Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies
21. Association Between Interstitial Lung Abnormalities and All-Cause Mortality
22. Chronic obstructive pulmonary disease: hiding in plain sight, a Statement from the COPD Foundation Medical and Scientific Advisory Committee
23. PHARMACOLOGIC MANAGEMENT AND OUTCOMES OF PATIENTS ON NON-TRIPLE MAINTENANCE THERAPY HOSPITALIZED FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A US HEALTHCARE DATABASE ANALYSIS
24. THE AVAILABILITY AND TRENDS OF BLOOD EOSINOPHIL DATA IN A LARGE NETWORK OF US HEALTH SYSTEMS (IKANOS EOS PREVIEW STUDY)
25. Comorbidities in Patients With Chronic Obstructive Pulmonary Disease
26. A Historical Perspective of Pulmonary Rehabilitation
27. Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study.
28. Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease
29. Supplementation with Qter® and Creatine improves functional performance in COPD patients on long term oxygen therapy
30. Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease
31. Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial
32. GOLD 2023 Update: Implications for Clinical Practice
33. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
34. Effect of a single exacerbation on decline in lung function in COPD
35. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
36. Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD
37. Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trial
38. Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis
39. Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study
40. Air Pollution and COPD: GOLD 2023 committee REport
41. Differential Diagnosis of Suspected COPD Exacerbations in the Acute Care Setting: Best Practice
42. Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial
43. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO
44. Additional file 1 of Identifying chronic obstructive pulmonary disease from integrative omics and clustering in lung tissue
45. Pathophysiology of Chronic Obstructive Pulmonary Disease
46. Chronic Obstructive Pulmonary Disease and Lung Cancer: A Review for Clinicians
47. Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook.
48. Gold 2023: Highlights for primary care.
49. A Historical Perspective of Pulmonary Rehabilitation
50. Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.